TransMedics Q1 2026 Earnings EPS Misses Estimates by 52 as Revenue Data Unavailable ZENA Q4 2025 Earnings Significant EPS Miss Despite Positive Stock Reaction RCKY Q1 2026 Earnings EPS Misses Expectations as Revenue Details Remain Undisclosed ACIU Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Progress Continues Monte Rosa Therapeutics Inc GLUE Q1 2026 Earnings WiderthanExpected Loss Compounds Investor Caution OPCH Q1 2026 Earnings EPS Beats Estimates by 546 Amid Revenue Data Unavailability